The European Medicines Agency (EMA) issued guidance on the implementation of its Policy 0070 on the publication of clinical data for medicines, including with respect to anonymization of clinical reports for publication. (As background, please see our previous briefing on the EMA’s new approach to transparency of clinical studies here.) As of October 2016, all … Continue reading
EMA Issues Guidance on Anonymization in Clinical Trials
The European Medicines Agency (EMA) issued guidance on the implementation of its Policy 0070 on the publication of clinical data for medicines, including with respect to anonymization of clinical reports for publication. (As background, please see our previous briefing on the EMA’s new approach to transparency of clinical studies here.) As of October 2016, all … Continue reading
